Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05269654
Other study ID # Sculptra Aesthetic - Hip Dell
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 4, 2022
Est. completion date March 1, 2024

Study information

Verified date February 2022
Source Goldman, Butterwick, Fitzpatrick and Groff
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To assess the safety, efficacy and subject satisfaction associated with volumization of the hip dell with injectable poly-L-lactic acid (PLLA), or Sculptra® Aesthetic (Galderma Laboratories, Fort Worth, TX).


Description:

The primary objectives of this clinical trial is to assess efficacy of adipose tissue generation (adipogenesis) and volumization following treatment of the hip dell with injectable poly-L-lactic acid (PLLA, Sculptra® Aesthetic; Galderma Laboratories; Fort Worth, TX). Enrolled subjects will be randomized to two (2) treatment groups: "right hip dell treated" and "left hip dell treated". All subjects will receive three (3), single-sided injections of Sculptra® Aesthetic (Galderma Laboratories; Fort Worth, TX), performed one (1) month ± 7 days apart. Treatments will be provided to one side randomly assigned to either "right side" or "left side". The non-treatment side will receive bacteriostatic saline, injected in the same manner as Sculptra® Aesthetic. One (1) vial of Sculptra® Aesthetic, diluted to 8mL, will be used per treatment session. Subjects satisfying all inclusion and no exclusion criteria will be enrolled in this trial. Prior to receiving any study treatment, mandatory digital photography with overhead lighting and VECTRA® (Canfield Scientific, Inc.; Parsippany, NJ) 3D volumetric body photography will be obtained of each subject's treatment area. In order to participate in the study, subjects must provide written informed consent to have their photographs used for research, publication, and/or commercial purposes.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 20
Est. completion date March 1, 2024
Est. primary completion date December 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 30 Years to 60 Years
Eligibility Inclusion Criteria: - Adult females aged 30 to 60 years - Subjects in good general health based on investigator's judgment and medical history - Moderate to severe hip dell volume deficit as determined by the investigators - Must be willing to give and sign an informed consent form and photographic release form - Must have a stable body weight for at least six (6) months prior to study entry - Must be willing to maintain usual sun exposure, diet, and exercise routines for the duration of the study - Subject agrees to avoid tanning or use of sunless tanner during the entire course of the study - Negative urine pregnancy test result at the time of study entry (if applicable) - For female subjects of childbearing potential, must be willing to use an acceptable form of birth control during the entire course of the study. All systemic birth control measures must be in consistent use for at least 30 days prior to study enrollment. - A female is considered of childbearing potential unless she is postmenopausal, without a uterus and/or both ovaries, or has had a bilateral tubal ligation. - Acceptable methods of birth control are: oral contraceptives, contraceptive patches/rings/implants, Implanon®, Depo-Provera®, double-barrier methods (e.g., condoms and spermicide), abstinence, and/or vasectomy of partner with a documented second acceptable method of birth control, should the subject become sexually active. - Must be willing to comply with study treatments and complete the entire course of the study Exclusion Criteria: - Liposuction to bilateral hips, flanks, thighs, buttocks during the 12-month period prior to study treatment or any time during the course of the study - Mesotherapy, dermal fillers, biostimulatory injectables, fat grafting, radiofrequency device treatments, microfocused ultrasound device treatments, laser and light-based device treatments, microneedling, cryolipolysis, high intensity focused electromagnetic energy device treatment, or surgery (i.e., lower body lift, buttocks augmentation, abdominoplasty, etc.) during the 12-month period before study treatment c) Any investigational treatment for a volume deficit of the bilateral hip dell areas during the 12-month period before the study treatment d) Massage therapy during the 3-month period before study treatment. e) Creams/cosmeceuticals and/or home therapies to promote plumping of the bilateral hip dell area during the four-week period before study treatment f) Subjects with scarring in the treatment areas g) History of thrombosis, post-thrombosis syndrome, or any vascular disorder of the bilateral lower extremities - Any history of bleeding or coagulation disorders i) Subjects with tattoos or permanent implants in the treatment areas j) Subjects with a significant history or current evidence of a medical, psychological, or other disorder that, in the investigator's opinion, would preclude enrollment into the study - Subjects with a history of or presence of any skin condition/disease (including but not limited to any visible rash, atopic dermatitis, psoriasis, actinic keratoses, keratinocyte carcinoma, melanoma, etc.) in the treatment area that might interfere with the diagnosis or evaluation of study parameters - History of keloid or hypertrophic scarring - Subjects with an active bacterial, viral, or fungal infection of the treatment areas - Subjects who spray tanned or used sunless tanners in the treatment areas four (4) weeks prior to study treatment - History of lidocaine sensitivity deemed by the investigator to preclude the subject from enrolling into the study - Subjects planning any cosmetic procedure to the treatment areas during the study period, other than the treatment that will be performed by the investigator - Presence of incompletely healed wound(s) in the treatment area - Subjects who are on an immunosuppressant or have an autoimmune condition - Female subjects who are pregnant, planning a pregnancy, or breast feeding during the study - Current participation or participation within 30 days prior to the start of this study in a drug or other investigational research study

Study Design


Related Conditions & MeSH terms


Intervention

Device:
injectable poly-L-lactic acid
Injectable biostimulant for volume loss
Other:
Normal Saline
Sham Comparator

Locations

Country Name City State
United States West Dermatology Research Center/Cosmetic Laser Dermatology San Diego California

Sponsors (2)

Lead Sponsor Collaborator
Goldman, Butterwick, Fitzpatrick and Groff Galderma R&D

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Histological Analysis Comparison of measure of adipose tissue in biopsies taken from device and sham treated areas prior to baseline and at followup visits Baseline to three months post final treatment
Primary Histological Analysis Comparison of measure of adipose tissue in biopsies taken from device and sham treated areas prior to baseline and at followup visits Baseline to six months post final treatment
Primary Volumetric Analysis Analysis of tissue volume in treatment zones based on measurements obtained via 3D photography Pre-Treatment Visit 2/ Baseline
Primary Volumetric Analysis Analysis of tissue volume in treatment zones based on measurements obtained via 3D photography Pre-Treatment Visit 3/ Day 14
Primary Volumetric Analysis Analysis of tissue volume in treatment zones based on measurements obtained via 3D photography Pre-Treatment Visit 4/ Day 44
Primary Volumetric Analysis Analysis of tissue volume in treatment zones based on measurements obtained via 3D photography Pre-Treatment Visit 5/ Day 74
Primary Volumetric Analysis Analysis of tissue volume in treatment zones based on measurements obtained via 3D photography Visit 6/ Day 104
Primary Volumetric Analysis Analysis of tissue volume in treatment zones based on measurements obtained via 3D photography Visit 7/ Day 164
Primary Volumetric Analysis Analysis of tissue volume in treatment zones based on measurements obtained via 3D photography Visit 9/ Day 254
Primary Volumetric Analysis Analysis of tissue volume in treatment zones based on measurements obtained via 3D photography Visit 11/ Day 344
Primary Physician Global Aesthetic Improvement Scale Blinded-Evaluator assessment of change in appearance of treated areas where 1 + Very Much Improved, 2 = Much Improved, 3 = Improved, 4 = No Change, and 5 = Worse 1 Month Follow-Up visit
Primary Physician Global Aesthetic Improvement Scale Blinded-Evaluator assessment of change in appearance of treated areas where 1 + Very Much Improved, 2 = Much Improved, 3 = Improved, 4 = No Change, and 5 = Worse 3 Month Follow-Up visit
Primary Physician Global Aesthetic Improvement Scale Blinded-Evaluator assessment of change in appearance of treated areas where 1 + Very Much Improved, 2 = Much Improved, 3 = Improved, 4 = No Change, and 5 = Worse 6 Month Follow-Up visit
Primary Physician Global Aesthetic Improvement Scale Blinded-Evaluator assessment of change in appearance of treated areas where 1 + Very Much Improved, 2 = Much Improved, 3 = Improved, 4 = No Change, and 5 = Worse 9 Month Follow-Up visit
Primary Identification of correct Treatment Area (Right vs Left Hip) Blinded-Evaluator performed assessment of which side received study treatment and which received sham 9 Month Follow-Up visit
Secondary Collagen Analysis Quantitative analysis of collagen amounts based on histology Upon analysis of biopsies collected at Day 0 and 3 and 6 Month Follow-Up visits
Secondary Elastin Analysis Quantitative analysis of elastin amounts based on histology Upon analysis of biopsies collected at Day 0 and 3 and 6 Month Follow-Up visits
Secondary Skin Thickness Ultrasound imaging measurements of skin thickness/thickness of dermis Day 0 and 3, 6, and 9 Month Follow-Up visits
Secondary Subject Global Aesthetic Improvement Score Subject assessment of change in appearance of treated areas rated numerically from 1 to 5 with 1 being very much improved to 5 being worse 1, 3, 6, and 9 Month Follow-Up visits
Secondary Subject Satisfaction Questionairre Degree of subject satisfaction with treatment outcomes rated numerically from 0 to 4 with 0 being not satisfied to 4 being extremely satisfied 1, 3, 6, and 9 Month Follow-Up visits
Secondary Evaluation of Side Effects Assessment of treatment related adverse events by Investigator Day 44, Day 74, Day 104, Day 164, Day 178, Day 254, Day 268, Day 433
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06140628 - A 28-day Clinical Study on Facial Skin Rejuvenation N/A
Completed NCT01971736 - Efficacy of Long Pulsed 1064nm Laser for Facial Skin Tightening N/A
Completed NCT01713985 - Feasibility Study: Evaluation of Ulthera Versus Thermage for Treating the Face and Neck N/A
Completed NCT01713998 - Treatment of the Face and Neck With Lower Ulthera System Energy Settings N/A
Completed NCT01708382 - Feasibility Study: Lifting and Tightening of the Elbows N/A
Completed NCT01708252 - Feasibility Study: Treatment of Post-surgery and Surgery Naive Patients Who Failed to Respond to a Previous Ulthera Treatment N/A
Completed NCT04296201 - Evaluation of the Immediate Effect and Safety of DMA™ Novel Muscle Stimulation Technology N/A
Completed NCT06000839 - A Safety and Effectiveness Study of CELLBOOSTER® Lift (Stabilized Booster Complex Using CHAC Technology) N/A
Completed NCT06366503 - Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation N/A
Completed NCT05929625 - Radiofrequency and Ultrasound for Improvement of Skin Laxity and Wrinkles: Efficacy and Safety Evaluation N/A
Terminated NCT01713569 - Feasibility Study: Histological Characterization After Treatment With the Ulthera® System N/A
Completed NCT01519934 - A Retrospective Study to Evaluate the Effectiveness of the Ulthera System N/A
Completed NCT05605691 - Post-Market Lower Eyelid Treatment With Renuvion in Greece N/A
Completed NCT04477187 - Clinical Assessment of Skin Tightening and Contour Change of Submental Tissue Using Bipolar Radiofrequency Microneedling N/A
Completed NCT05590364 - Aesthetic Performance and Tolerance of an Injective Intradermal Treatment for the Skin Roughness and Laxity of Back of the Hands N/A
Active, not recruiting NCT06243744 - Histological Evaluation of Human Skin Bx to Assess the Effects of APR Tx as an Adjunct Procedure in Facelift Surgery N/A
Completed NCT04146584 - Safety and Efficacy of SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow Phase 2
Recruiting NCT05750901 - Evaluation of Fractional Ablative Laser Treatment for Skin Conditions N/A
Completed NCT04721600 - Evaluation of the Evoke Radiofrequency Device for Improvement of Skin Appearance N/A
Recruiting NCT06157567 - Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System N/A